Literature DB >> 15716529

Ten year recurrence after first ever stroke in a Japanese community: the Hisayama study.

J Hata1, Y Tanizaki, Y Kiyohara, I Kato, M Kubo, K Tanaka, K Okubo, H Nakamura, Y Oishi, S Ibayashi, M Iida.   

Abstract

BACKGROUND: Very few population based cohort studies have focused on the long term recurrence of stroke.
OBJECTIVE: To examine 10 year cumulative recurrence rates for stroke in a Japanese cohort according to pathological type and clinical subtype of brain infarction.
METHODS: During a 32 year follow up of 1621 subjects >/=40 years of age, 410 developed first ever stroke. These were followed up prospectively for 10 years after stroke onset.
RESULTS: During follow up, 108 (26%) experienced recurrent stroke. The cumulative recurrence rates were 35.3% at five years and 51.3% at 10 years. The 10 year recurrence rates of subarachnoid haemorrhage (SAH), brain haemorrhage, and brain infarction were 70.0%, 55.6%, and 49.7%, respectively; the difference between SAH and brain infarction was significant (p = 0.004). Most recurrent episodes after SAH or brain haemorrhage happened within a year after the index stroke, whereas recurrence of brain infarction increased consistently throughout the observation period. Cardioembolic stroke had a higher recurrence rate (75.2%) than lacunar infarction (46.8%) (p = 0.049). The 10 year risk of stroke recurrence increased with age after lacunar or atherothrombotic brain infarction, but not after the other types or subtypes. After atherothrombotic brain infarction, cardioembolic stroke, or SAH, the type and subtype of most recurrent strokes were the same as for the index stroke, but recurrence after lacunar infarction or brain haemorrhage showed divergent patterns.
CONCLUSIONS: Japanese people have higher recurrence rates of stroke than other populations. Recurrence rate after a first brain infarct increases consistently through the next 10 years.

Entities:  

Mesh:

Year:  2005        PMID: 15716529      PMCID: PMC1739549          DOI: 10.1136/jnnp.2004.038166

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

Review 1.  Lacunar strokes and infarcts: a review.

Authors:  C M Fisher
Journal:  Neurology       Date:  1982-08       Impact factor: 9.910

2.  Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study.

Authors:  P L Kolominsky-Rabas; M Weber; O Gefeller; B Neundoerfer; P U Heuschmann
Journal:  Stroke       Date:  2001-12-01       Impact factor: 7.914

3.  Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence.

Authors:  G W Petty; R D Brown; J P Whisnant; J D Sicks; W M O'Fallon; D O Wiebers
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

4.  Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study.

Authors:  Y Tanizaki; Y Kiyohara; I Kato; H Iwamoto; K Nakayama; N Shinohara; H Arima; K Tanaka; S Ibayashi; M Fujishima
Journal:  Stroke       Date:  2000-11       Impact factor: 7.914

5.  Long-term risk of first recurrent stroke in the Perth Community Stroke Study.

Authors:  G J Hankey; K Jamrozik; R J Broadhurst; S Forbes; P W Burvill; C S Anderson; E G Stewart-Wynne
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

6.  Survival and recurrence following stroke. The Framingham study.

Authors:  R L Sacco; P A Wolf; W B Kannel; P M McNamara
Journal:  Stroke       Date:  1982 May-Jun       Impact factor: 7.914

7.  Ten-year prognosis of stroke and risk factors for death in a Japanese community: the Hisayama study.

Authors:  Yutaka Kiyohara; Michiaki Kubo; Isao Kato; Yimihiro Tanizaki; Keiichi Tanaka; Ken Okubo; Hidetoshi Nakamura; Mitsuo Iida
Journal:  Stroke       Date:  2003-09-18       Impact factor: 7.914

8.  Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register.

Authors:  Thomas Hillen; Catherine Coshall; Kate Tilling; Anthony G Rudd; Rory McGovern; Charles D A Wolfe
Journal:  Stroke       Date:  2003-05-15       Impact factor: 7.914

9.  Mechanisms of second and further strokes.

Authors:  H Yamamoto; J Bogousslavsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

10.  Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study.

Authors:  Michiaki Kubo; Yutaka Kiyohara; Isao Kato; Yumihiro Tanizaki; Hisatomi Arima; Keiichi Tanaka; Hidetoshi Nakamura; Ken Okubo; Mitsuo Iida
Journal:  Stroke       Date:  2003-09-04       Impact factor: 7.914

View more
  22 in total

1.  Stroke recurrence and mortality in northeastern Greece: the Evros Stroke Registry.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Athanasia Patousi; Maria Pikilidou; Theodosis Birbilis; Michael Mantatzis; Maria Yavropoulou; Christina Zompola; Sokratis Triantafyllou; Nikolaos Papanas; Panagiotis Skendros; Aikaterini Terzoudi; George S Georgiadis; Pantelis Zebekakis; Efstratios Maltezos; Charitomeni Piperidou; Ioannis Heliopoulos; Konstantinos Vadikolias
Journal:  J Neurol       Date:  2018-08-20       Impact factor: 4.849

2.  The Frequency and Timing of Recurrent Stroke: An Analysis of Routine Health Insurance Data.

Authors:  Jona T Stahmeyer; Sarah Stubenrauch; Siegfried Geyer; Karin Weissenborn; Sveja Eberhard
Journal:  Dtsch Arztebl Int       Date:  2019-10-18       Impact factor: 5.594

3.  Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study.

Authors:  Hiroaki Matsuoka; Iwao Kuwajima; Kazuyuki Shimada; Hideo Mitamura; Takao Saruta
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-09       Impact factor: 3.738

4.  The dynamics of mortality in follow-up time after an acute myocardial infarction, lower extremity arterial disease and ischemic stroke.

Authors:  Ilonca Vaartjes; Ineke van Dis; Diederick E Grobbee; Michiel L Bots
Journal:  BMC Cardiovasc Disord       Date:  2010-11-25       Impact factor: 2.298

5.  Three-year survival and recurrence after first-ever stroke: the Joinville stroke registry.

Authors:  Norberto Luiz Cabral; Milena Muller; Selma Cristina Franco; Alexandre Longo; Carla Moro; Vivian Nagel; Rafaela B Liberato; Adriana C Garcia; Vanessa G Venancio; Anderson Rr Gonçalves
Journal:  BMC Neurol       Date:  2015-05-01       Impact factor: 2.474

6.  Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event.

Authors:  Naohisa Hosomi; Yoji Nagai; Kazuo Kitagawa; Yoko Nakagawa; Shiro Aoki; Tomohisa Nezu; Tatsuo Kagimura; Hirofumi Maruyama; Hideki Origasa; Kazuo Minematsu; Shinichiro Uchiyama; Masayasu Matsumoto
Journal:  J Atheroscler Thromb       Date:  2017-09-16       Impact factor: 4.928

7.  Characteristics, risk factors and mortality of stroke patients in Kyoto, Japan.

Authors:  Kazuo Shigematsu; Hiromi Nakano; Yoshiyuki Watanabe; Tatsuyuki Sekimoto; Kouichiro Shimizu; Akihiko Nishizawa; Masahiro Makino; Atsushi Okumura; Kazuhiko Bando; Yasushi Kitagawa
Journal:  BMJ Open       Date:  2013-03-05       Impact factor: 2.692

8.  Expected value of the additional state in evaluating the method of quantification and uncertainty of additional states in an analytical model of grade I hypertension.

Authors:  Takeshi Uchikura; Makoto Kobayashi; Masayuki Hashiguchi; Mayumi Mochizuki
Journal:  J Pharm Health Care Sci       Date:  2015-01-28

Review 9.  Epidemiology and registry studies of stroke in Japan.

Authors:  Kazunori Toyoda
Journal:  J Stroke       Date:  2013-01-31       Impact factor: 6.967

10.  A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study.

Authors:  Takanori Ikeda; Masahiro Yasaka; Makoto Kida; Miki Imura
Journal:  Patient Prefer Adherence       Date:  2018-01-17       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.